SCHEMBL6563191

SCHEMBL6563191

Oc1ccc(Cl)c(O)c1.Oc1ccc(Cl)c(O)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.65
TSHR P16473 2/20 0.62
ALDH1A1 P00352 2/20 0.62
CYP3A4 P08684 2/20 0.62
TDP1 Q9NUW8 1/20 0.62
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
CA14 Q9ULX7 1/20 0.56
TTR P02766 1/20 0.48
HPGD P15428 1/20 0.48
TYR P14679 1/20 0.46
ESR1 P03372 4/20 0.45
ESR2 Q92731 2/20 0.45
CES2 O00748 1/20 0.44
MAPK1 P28482 1/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33883 1.00
SCHEMBL29353342 1.00
Hydrochloric Acid SCHEMBL29135541 0.97 HSD17B10 (0.62) HSD17B10TSHRALDH1A1CYP3A4TDP1
Phloroglucinol SCHEMBL4934126 0.95 HSD17B10 (0.59) HSD17B10TSHRALDH1A1CYP3A4TDP1
Resorcinol SCHEMBL6870415 0.90 ALDH1A1 (0.57) HSD17B10TSHRALDH1A1CYP3A4TDP1
Methoxymethane SCHEMBL9836653 0.90 HSD17B10 (0.54) HSD17B10TSHRALDH1A1CYP3A4TDP1
Phenol SCHEMBL28975672 0.88 HSD17B10 (0.52) HSD17B10TSHRALDH1A1CYP3A4TDP1
Pentachlorophenol SCHEMBL15904847 0.88 HSD17B10 (0.52) HSD17B10TSHRALDH1A1CYP3A4TDP1
SCHEMBL9666291 0.88 HSD17B10 (0.52) HSD17B10TSHRALDH1A1CYP3A4TDP1
Pyrogallol SCHEMBL8418093 0.86 HSD17B10 (0.52) HSD17B10TSHRALDH1A1CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863950-B1 HAIR DYEING COMPOSITION NOVOZYMES AS (DK) 2001-10-10 EP claimed
EP-1137391-B1 METHOD FOR TREATING HAIR NOVOZYMES AS (DK) 2004-11-03 EP disclosed
US-6572843-B1 Combining permanent dyeing and straightening; applying to reduced hair an oxidizing enzyme (Laccase), a mediator, and a chemical oxidizing agent that produces hydrogen peroxide NOVOZYMES, A/S (DK) 2003-06-03 US disclosed
EP-0963192-B1 DIAMINOBENZOIC ACID DERIVATIVES AS DYE PRECURSORS NOVOZYMES AS (DK) 2003-01-08 EP disclosed
EP-1076494-B1 RE-FORMATION OF KERATINOUS FIBRE CROSS LINKS NOVOZYMES AS (DK) 2002-09-18 EP disclosed
US-20020007524-A1 Contacting fibers in a dry state with an oxidoreductase and a dye precursor; reduced hair damage NOVOZYMES A/S (DK) 2002-01-24 US disclosed
US-20020004958-A1 Dyeing substrates NOVOZYMES A/S (DK) 2002-01-17 US disclosed
EP-0863950-B1 HAIR DYEING COMPOSITION NOVOZYMES AS (DK) 2001-10-10 EP disclosed
EP-0865465-B1 LACCASES WITH IMPROVED DYEING PROPERTIES NOVOZYMES AS (DK) 2001-05-30 EP disclosed
US-5948121-A PERMANENT DYEING OF KERATINOUS FIBERS. LACCASE DERIVED FROM A STRAIN OF THE GENUS MYCELIOPHTHORA NOVO NORDISK A/S (DK) 1999-09-07 US disclosed
US-5899212-A CLEAVAGE OF DISULFIDE BONDS, OXIDOREDUCTASE NOVO NORDISK A/S (DK) 1999-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020004958-A1 Dyeing substrates KRT18, COL1A1, MT-ND1 HSD17B10 67/4885TSHR 4873/4885ALDH1A1 16/4885
US-20020007524-A1 Contacting fibers in a dry state with an oxidoreductase and a dye precursor; reduced hair damage KRT18, CYB5R3, ADH7 HSD17B10 64/4885TSHR 3797/4885ALDH1A1 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.